Skip to main content

Advertisement

Table 1 Prevalence and relative sensitivity and specificity rates of the PCR-ELISA laboratorial and commercial platforms, taking Kato-Katz technique (12 slides) as reference for schistosomiasis mansoni diagnosis

From: Development of a laboratorial platform for diagnosis of schistosomiasis mansoni by PCR-ELISA

Assays Prevalence rate (CI 95%) Relative sensitivity (CI 95%) Relative specificity (CI 95%)
PCR-ELISA laboratorial platform (500 mg feces) 52/206 (25.2%) (19.5–31.8) 37/38 (97.4%) (86.5–99.5) 153/168 (91.1%) (85.8–94.5)
PCR-ELISA commercial platform (500 mg feces) 62/206 (30.1%) (23.9–36.9) 37/38 (97.4%) (86.5–99.5) 143/168 (85.1%) (79–89.7)
  1. Difference between prevalence rates of the PCR-ELISA laboratorial and commercial platforms, p = 0.13
  2. Difference between relative specificity rates of the PCR-ELISA laboratorial and commercial platforms, p = 0.03